nodes	percent_of_prediction	percent_of_DWPC	metapath
Methysergide—SIGMAR1—Progesterone—uterine cancer	0.653	1	CbGbCtD
Methysergide—Leg pain—Progesterone—uterine cancer	0.00838	0.034	CcSEcCtD
Methysergide—Leg pain—Medroxyprogesterone Acetate—uterine cancer	0.00759	0.0308	CcSEcCtD
Methysergide—HTR1E—myometrium—uterine cancer	0.00726	0.0767	CbGeAlD
Methysergide—HTR1B—artery—uterine cancer	0.00711	0.0751	CbGeAlD
Methysergide—HTR1D—artery—uterine cancer	0.00688	0.0727	CbGeAlD
Methysergide—SIGMAR1—Levonorgestrel—Progesterone—uterine cancer	0.00608	1	CbGdCrCtD
Methysergide—HTR7—artery—uterine cancer	0.00548	0.0579	CbGeAlD
Methysergide—Heartburn—Medroxyprogesterone Acetate—uterine cancer	0.00509	0.0207	CcSEcCtD
Methysergide—Gravitational oedema—Epirubicin—uterine cancer	0.00454	0.0185	CcSEcCtD
Methysergide—Gravitational oedema—Doxorubicin—uterine cancer	0.0042	0.0171	CcSEcCtD
Methysergide—Leg edema—Epirubicin—uterine cancer	0.00412	0.0167	CcSEcCtD
Methysergide—HTR1E—female gonad—uterine cancer	0.00385	0.0407	CbGeAlD
Methysergide—Leg edema—Doxorubicin—uterine cancer	0.00381	0.0155	CcSEcCtD
Methysergide—Lightheadedness—Progesterone—uterine cancer	0.00346	0.0141	CcSEcCtD
Methysergide—HTR2A—artery—uterine cancer	0.00342	0.0361	CbGeAlD
Methysergide—Thrombophlebitis—Progesterone—uterine cancer	0.00324	0.0132	CcSEcCtD
Methysergide—SIGMAR1—myometrium—uterine cancer	0.0031	0.0328	CbGeAlD
Methysergide—HTR2B—myometrium—uterine cancer	0.00309	0.0327	CbGeAlD
Methysergide—Euphoric mood—Medroxyprogesterone Acetate—uterine cancer	0.00301	0.0122	CcSEcCtD
Methysergide—Thrombophlebitis—Medroxyprogesterone Acetate—uterine cancer	0.00294	0.0119	CcSEcCtD
Methysergide—Pain in extremity—Progesterone—uterine cancer	0.00281	0.0114	CcSEcCtD
Methysergide—Pain in extremity—Medroxyprogesterone Acetate—uterine cancer	0.00254	0.0103	CcSEcCtD
Methysergide—SIGMAR1—uterine cervix—uterine cancer	0.00241	0.0255	CbGeAlD
Methysergide—HTR2B—uterine cervix—uterine cancer	0.00241	0.0254	CbGeAlD
Methysergide—Ataxia—Medroxyprogesterone Acetate—uterine cancer	0.00239	0.00972	CcSEcCtD
Methysergide—SIGMAR1—smooth muscle tissue—uterine cancer	0.00234	0.0248	CbGeAlD
Methysergide—HTR2B—smooth muscle tissue—uterine cancer	0.00234	0.0247	CbGeAlD
Methysergide—Orthostatic hypotension—Medroxyprogesterone Acetate—uterine cancer	0.00232	0.00944	CcSEcCtD
Methysergide—SIGMAR1—decidua—uterine cancer	0.0023	0.0243	CbGeAlD
Methysergide—HTR2B—decidua—uterine cancer	0.00229	0.0242	CbGeAlD
Methysergide—Dysuria—Progesterone—uterine cancer	0.00227	0.00922	CcSEcCtD
Methysergide—Pain—Carboplatin—uterine cancer	0.00225	0.00913	CcSEcCtD
Methysergide—Weight increased—Progesterone—uterine cancer	0.00221	0.00897	CcSEcCtD
Methysergide—Weight decreased—Progesterone—uterine cancer	0.00219	0.00892	CcSEcCtD
Methysergide—SIGMAR1—endometrium—uterine cancer	0.00218	0.0231	CbGeAlD
Methysergide—HTR2B—endometrium—uterine cancer	0.00218	0.023	CbGeAlD
Methysergide—Drowsiness—Progesterone—uterine cancer	0.00216	0.00879	CcSEcCtD
Methysergide—SIGMAR1—mammalian vulva—uterine cancer	0.00211	0.0223	CbGeAlD
Methysergide—HTR7—epithelium—uterine cancer	0.00208	0.022	CbGeAlD
Methysergide—Body temperature increased—Carboplatin—uterine cancer	0.00208	0.00844	CcSEcCtD
Methysergide—Dysuria—Medroxyprogesterone Acetate—uterine cancer	0.00206	0.00836	CcSEcCtD
Methysergide—HTR1A—renal system—uterine cancer	0.00202	0.0213	CbGeAlD
Methysergide—SIGMAR1—uterus—uterine cancer	0.00201	0.0213	CbGeAlD
Methysergide—HTR2B—uterus—uterine cancer	0.00201	0.0212	CbGeAlD
Methysergide—HTR7—smooth muscle tissue—uterine cancer	0.002	0.0212	CbGeAlD
Methysergide—HTR1B—female reproductive system—uterine cancer	0.002	0.0212	CbGeAlD
Methysergide—Weight increased—Medroxyprogesterone Acetate—uterine cancer	0.002	0.00813	CcSEcCtD
Methysergide—Weight decreased—Medroxyprogesterone Acetate—uterine cancer	0.00199	0.00808	CcSEcCtD
Methysergide—Drowsiness—Medroxyprogesterone Acetate—uterine cancer	0.00196	0.00797	CcSEcCtD
Methysergide—HTR1D—female reproductive system—uterine cancer	0.00194	0.0205	CbGeAlD
Methysergide—HTR7—renal system—uterine cancer	0.00193	0.0204	CbGeAlD
Methysergide—HTR2C—female reproductive system—uterine cancer	0.00192	0.0203	CbGeAlD
Methysergide—Oedema peripheral—Progesterone—uterine cancer	0.00191	0.00778	CcSEcCtD
Methysergide—HTR2B—female reproductive system—uterine cancer	0.0018	0.0191	CbGeAlD
Methysergide—Oedema peripheral—Medroxyprogesterone Acetate—uterine cancer	0.00173	0.00705	CcSEcCtD
Methysergide—Alopecia—Progesterone—uterine cancer	0.00172	0.00697	CcSEcCtD
Methysergide—SIGMAR1—female gonad—uterine cancer	0.00164	0.0174	CbGeAlD
Methysergide—Back pain—Progesterone—uterine cancer	0.00164	0.00665	CcSEcCtD
Methysergide—SIGMAR1—vagina—uterine cancer	0.00164	0.0173	CbGeAlD
Methysergide—HTR2B—vagina—uterine cancer	0.00163	0.0172	CbGeAlD
Methysergide—Neutropenia—Dactinomycin—uterine cancer	0.0016	0.00652	CcSEcCtD
Methysergide—Ill-defined disorder—Progesterone—uterine cancer	0.00157	0.00638	CcSEcCtD
Methysergide—Alopecia—Medroxyprogesterone Acetate—uterine cancer	0.00155	0.00632	CcSEcCtD
Methysergide—HTR7—female reproductive system—uterine cancer	0.00154	0.0163	CbGeAlD
Methysergide—Malaise—Progesterone—uterine cancer	0.00152	0.0062	CcSEcCtD
Methysergide—Back pain—Medroxyprogesterone Acetate—uterine cancer	0.00148	0.00602	CcSEcCtD
Methysergide—Convulsion—Progesterone—uterine cancer	0.00146	0.00595	CcSEcCtD
Methysergide—Pleural effusion—Epirubicin—uterine cancer	0.00145	0.00589	CcSEcCtD
Methysergide—Chest pain—Progesterone—uterine cancer	0.00144	0.00585	CcSEcCtD
Methysergide—Myalgia—Progesterone—uterine cancer	0.00144	0.00585	CcSEcCtD
Methysergide—Arthralgia—Progesterone—uterine cancer	0.00144	0.00585	CcSEcCtD
Methysergide—Discomfort—Progesterone—uterine cancer	0.00142	0.00578	CcSEcCtD
Methysergide—Ill-defined disorder—Medroxyprogesterone Acetate—uterine cancer	0.00142	0.00578	CcSEcCtD
Methysergide—Hyperaesthesia—Epirubicin—uterine cancer	0.00141	0.00574	CcSEcCtD
Methysergide—Malaise—Medroxyprogesterone Acetate—uterine cancer	0.00138	0.00561	CcSEcCtD
Methysergide—Oedema—Progesterone—uterine cancer	0.00138	0.00561	CcSEcCtD
Methysergide—Tachycardia—Progesterone—uterine cancer	0.00135	0.00547	CcSEcCtD
Methysergide—Pleural effusion—Doxorubicin—uterine cancer	0.00134	0.00545	CcSEcCtD
Methysergide—Convulsion—Medroxyprogesterone Acetate—uterine cancer	0.00133	0.00539	CcSEcCtD
Methysergide—Hyperaesthesia—Doxorubicin—uterine cancer	0.00131	0.00531	CcSEcCtD
Methysergide—Myalgia—Medroxyprogesterone Acetate—uterine cancer	0.0013	0.0053	CcSEcCtD
Methysergide—Arthralgia—Medroxyprogesterone Acetate—uterine cancer	0.0013	0.0053	CcSEcCtD
Methysergide—Chest pain—Medroxyprogesterone Acetate—uterine cancer	0.0013	0.0053	CcSEcCtD
Methysergide—HTR2A—epithelium—uterine cancer	0.0013	0.0137	CbGeAlD
Methysergide—Discomfort—Medroxyprogesterone Acetate—uterine cancer	0.00129	0.00524	CcSEcCtD
Methysergide—Flushing—Dactinomycin—uterine cancer	0.00127	0.00518	CcSEcCtD
Methysergide—Musculoskeletal discomfort—Progesterone—uterine cancer	0.00126	0.00511	CcSEcCtD
Methysergide—Oedema—Medroxyprogesterone Acetate—uterine cancer	0.00125	0.00508	CcSEcCtD
Methysergide—HTR2A—smooth muscle tissue—uterine cancer	0.00125	0.0132	CbGeAlD
Methysergide—Insomnia—Progesterone—uterine cancer	0.00125	0.00507	CcSEcCtD
Methysergide—Paraesthesia—Progesterone—uterine cancer	0.00124	0.00504	CcSEcCtD
Methysergide—Dyspnoea—Progesterone—uterine cancer	0.00123	0.005	CcSEcCtD
Methysergide—Somnolence—Progesterone—uterine cancer	0.00123	0.00499	CcSEcCtD
Methysergide—Thrombocytopenia—Medroxyprogesterone Acetate—uterine cancer	0.00122	0.00498	CcSEcCtD
Methysergide—Tachycardia—Medroxyprogesterone Acetate—uterine cancer	0.00122	0.00496	CcSEcCtD
Methysergide—Dyspepsia—Progesterone—uterine cancer	0.00121	0.00494	CcSEcCtD
Methysergide—Alopecia—Dactinomycin—uterine cancer	0.00121	0.00493	CcSEcCtD
Methysergide—Oliguria—Epirubicin—uterine cancer	0.0012	0.00489	CcSEcCtD
Methysergide—HTR2A—renal system—uterine cancer	0.0012	0.0127	CbGeAlD
Methysergide—Gastrointestinal disorder—Progesterone—uterine cancer	0.00119	0.00484	CcSEcCtD
Methysergide—Fatigue—Progesterone—uterine cancer	0.00119	0.00483	CcSEcCtD
Methysergide—Pain—Progesterone—uterine cancer	0.00118	0.0048	CcSEcCtD
Methysergide—Constipation—Progesterone—uterine cancer	0.00118	0.0048	CcSEcCtD
Methysergide—Neutropenia—Etoposide—uterine cancer	0.00116	0.00472	CcSEcCtD
Methysergide—Musculoskeletal discomfort—Medroxyprogesterone Acetate—uterine cancer	0.00114	0.00463	CcSEcCtD
Methysergide—Feeling abnormal—Progesterone—uterine cancer	0.00114	0.00462	CcSEcCtD
Methysergide—Insomnia—Medroxyprogesterone Acetate—uterine cancer	0.00113	0.0046	CcSEcCtD
Methysergide—Gastrointestinal pain—Progesterone—uterine cancer	0.00113	0.00459	CcSEcCtD
Methysergide—Paraesthesia—Medroxyprogesterone Acetate—uterine cancer	0.00112	0.00456	CcSEcCtD
Methysergide—Dyspnoea—Medroxyprogesterone Acetate—uterine cancer	0.00111	0.00453	CcSEcCtD
Methysergide—Oliguria—Doxorubicin—uterine cancer	0.00111	0.00453	CcSEcCtD
Methysergide—Somnolence—Medroxyprogesterone Acetate—uterine cancer	0.00111	0.00452	CcSEcCtD
Methysergide—Ill-defined disorder—Dactinomycin—uterine cancer	0.00111	0.00451	CcSEcCtD
Methysergide—Dyspepsia—Medroxyprogesterone Acetate—uterine cancer	0.0011	0.00447	CcSEcCtD
Methysergide—Abdominal pain—Progesterone—uterine cancer	0.00109	0.00443	CcSEcCtD
Methysergide—Body temperature increased—Progesterone—uterine cancer	0.00109	0.00443	CcSEcCtD
Methysergide—Gastrointestinal disorder—Medroxyprogesterone Acetate—uterine cancer	0.00108	0.00439	CcSEcCtD
Methysergide—Fatigue—Medroxyprogesterone Acetate—uterine cancer	0.00108	0.00438	CcSEcCtD
Methysergide—Malaise—Dactinomycin—uterine cancer	0.00108	0.00438	CcSEcCtD
Methysergide—Constipation—Medroxyprogesterone Acetate—uterine cancer	0.00107	0.00435	CcSEcCtD
Methysergide—SIGMAR1—lymph node—uterine cancer	0.00106	0.0112	CbGeAlD
Methysergide—HTR2B—lymph node—uterine cancer	0.00106	0.0112	CbGeAlD
Methysergide—Blood urea increased—Epirubicin—uterine cancer	0.00105	0.00426	CcSEcCtD
Methysergide—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	0.00103	0.00419	CcSEcCtD
Methysergide—Gastrointestinal pain—Medroxyprogesterone Acetate—uterine cancer	0.00102	0.00416	CcSEcCtD
Methysergide—Myalgia—Dactinomycin—uterine cancer	0.00102	0.00413	CcSEcCtD
Methysergide—Discomfort—Dactinomycin—uterine cancer	0.001	0.00409	CcSEcCtD
Methysergide—Asthenia—Progesterone—uterine cancer	0.00099	0.00402	CcSEcCtD
Methysergide—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.000988	0.00402	CcSEcCtD
Methysergide—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	0.000988	0.00402	CcSEcCtD
Methysergide—Oedema—Dactinomycin—uterine cancer	0.000975	0.00396	CcSEcCtD
Methysergide—Blood urea increased—Doxorubicin—uterine cancer	0.000969	0.00394	CcSEcCtD
Methysergide—HTR2A—female reproductive system—uterine cancer	0.000963	0.0102	CbGeAlD
Methysergide—Thrombocytopenia—Dactinomycin—uterine cancer	0.000955	0.00388	CcSEcCtD
Methysergide—Diarrhoea—Progesterone—uterine cancer	0.000944	0.00384	CcSEcCtD
Methysergide—Thrombophlebitis—Epirubicin—uterine cancer	0.00093	0.00378	CcSEcCtD
Methysergide—Flushing—Etoposide—uterine cancer	0.000922	0.00375	CcSEcCtD
Methysergide—Dizziness—Progesterone—uterine cancer	0.000912	0.00371	CcSEcCtD
Methysergide—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.000897	0.00365	CcSEcCtD
Methysergide—Musculoskeletal discomfort—Dactinomycin—uterine cancer	0.000888	0.00361	CcSEcCtD
Methysergide—Alopecia—Etoposide—uterine cancer	0.000878	0.00357	CcSEcCtD
Methysergide—Vomiting—Progesterone—uterine cancer	0.000877	0.00357	CcSEcCtD
Methysergide—HTR2A—vagina—uterine cancer	0.000871	0.00921	CbGeAlD
Methysergide—Rash—Progesterone—uterine cancer	0.00087	0.00354	CcSEcCtD
Methysergide—Dermatitis—Progesterone—uterine cancer	0.000869	0.00353	CcSEcCtD
Methysergide—Thrombophlebitis—Doxorubicin—uterine cancer	0.00086	0.0035	CcSEcCtD
Methysergide—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.000855	0.00348	CcSEcCtD
Methysergide—Fatigue—Dactinomycin—uterine cancer	0.000841	0.00342	CcSEcCtD
Methysergide—Back pain—Etoposide—uterine cancer	0.000836	0.0034	CcSEcCtD
Methysergide—Pain—Dactinomycin—uterine cancer	0.000834	0.00339	CcSEcCtD
Methysergide—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.000827	0.00336	CcSEcCtD
Methysergide—Nausea—Progesterone—uterine cancer	0.000819	0.00333	CcSEcCtD
Methysergide—Pain in extremity—Epirubicin—uterine cancer	0.000805	0.00327	CcSEcCtD
Methysergide—Feeling abnormal—Dactinomycin—uterine cancer	0.000804	0.00327	CcSEcCtD
Methysergide—Ill-defined disorder—Etoposide—uterine cancer	0.000802	0.00326	CcSEcCtD
Methysergide—Gastrointestinal pain—Dactinomycin—uterine cancer	0.000797	0.00324	CcSEcCtD
Methysergide—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000795	0.00323	CcSEcCtD
Methysergide—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000788	0.0032	CcSEcCtD
Methysergide—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000787	0.0032	CcSEcCtD
Methysergide—Malaise—Etoposide—uterine cancer	0.00078	0.00317	CcSEcCtD
Methysergide—Abdominal pain—Dactinomycin—uterine cancer	0.000771	0.00313	CcSEcCtD
Methysergide—Body temperature increased—Dactinomycin—uterine cancer	0.000771	0.00313	CcSEcCtD
Methysergide—Ataxia—Epirubicin—uterine cancer	0.000757	0.00308	CcSEcCtD
Methysergide—Convulsion—Etoposide—uterine cancer	0.000749	0.00305	CcSEcCtD
Methysergide—Pain in extremity—Doxorubicin—uterine cancer	0.000745	0.00303	CcSEcCtD
Methysergide—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000743	0.00302	CcSEcCtD
Methysergide—Chest pain—Etoposide—uterine cancer	0.000736	0.00299	CcSEcCtD
Methysergide—Orthostatic hypotension—Epirubicin—uterine cancer	0.000735	0.00299	CcSEcCtD
Methysergide—Discomfort—Etoposide—uterine cancer	0.000727	0.00296	CcSEcCtD
Methysergide—Ataxia—Doxorubicin—uterine cancer	0.0007	0.00285	CcSEcCtD
Methysergide—Asthenia—Dactinomycin—uterine cancer	0.0007	0.00284	CcSEcCtD
Methysergide—Thrombocytopenia—Etoposide—uterine cancer	0.000691	0.00281	CcSEcCtD
Methysergide—Tachycardia—Etoposide—uterine cancer	0.000689	0.0028	CcSEcCtD
Methysergide—Eosinophilia—Epirubicin—uterine cancer	0.000689	0.0028	CcSEcCtD
Methysergide—Orthostatic hypotension—Doxorubicin—uterine cancer	0.00068	0.00276	CcSEcCtD
Methysergide—Diarrhoea—Dactinomycin—uterine cancer	0.000667	0.00271	CcSEcCtD
Methysergide—Neutropenia—Epirubicin—uterine cancer	0.00065	0.00264	CcSEcCtD
Methysergide—Dysuria—Epirubicin—uterine cancer	0.00065	0.00264	CcSEcCtD
Methysergide—Eosinophilia—Doxorubicin—uterine cancer	0.000637	0.00259	CcSEcCtD
Methysergide—Paraesthesia—Etoposide—uterine cancer	0.000634	0.00258	CcSEcCtD
Methysergide—Weight increased—Epirubicin—uterine cancer	0.000633	0.00257	CcSEcCtD
Methysergide—Weight decreased—Epirubicin—uterine cancer	0.000629	0.00256	CcSEcCtD
Methysergide—Dyspnoea—Etoposide—uterine cancer	0.000629	0.00256	CcSEcCtD
Methysergide—Somnolence—Etoposide—uterine cancer	0.000627	0.00255	CcSEcCtD
Methysergide—Drowsiness—Epirubicin—uterine cancer	0.00062	0.00252	CcSEcCtD
Methysergide—Vomiting—Dactinomycin—uterine cancer	0.00062	0.00252	CcSEcCtD
Methysergide—Rash—Dactinomycin—uterine cancer	0.000615	0.0025	CcSEcCtD
Methysergide—Gastrointestinal disorder—Etoposide—uterine cancer	0.000609	0.00248	CcSEcCtD
Methysergide—Fatigue—Etoposide—uterine cancer	0.000608	0.00247	CcSEcCtD
Methysergide—Constipation—Etoposide—uterine cancer	0.000603	0.00245	CcSEcCtD
Methysergide—Pain—Etoposide—uterine cancer	0.000603	0.00245	CcSEcCtD
Methysergide—Neutropenia—Doxorubicin—uterine cancer	0.000602	0.00245	CcSEcCtD
Methysergide—Dysuria—Doxorubicin—uterine cancer	0.000602	0.00245	CcSEcCtD
Methysergide—Weight increased—Doxorubicin—uterine cancer	0.000586	0.00238	CcSEcCtD
Methysergide—Weight decreased—Doxorubicin—uterine cancer	0.000582	0.00237	CcSEcCtD
Methysergide—Feeling abnormal—Etoposide—uterine cancer	0.000582	0.00236	CcSEcCtD
Methysergide—Nausea—Dactinomycin—uterine cancer	0.000579	0.00235	CcSEcCtD
Methysergide—Gastrointestinal pain—Etoposide—uterine cancer	0.000577	0.00235	CcSEcCtD
Methysergide—Drowsiness—Doxorubicin—uterine cancer	0.000574	0.00233	CcSEcCtD
Methysergide—Abdominal pain—Etoposide—uterine cancer	0.000558	0.00227	CcSEcCtD
Methysergide—Body temperature increased—Etoposide—uterine cancer	0.000558	0.00227	CcSEcCtD
Methysergide—Oedema peripheral—Epirubicin—uterine cancer	0.000549	0.00223	CcSEcCtD
Methysergide—Flushing—Epirubicin—uterine cancer	0.000517	0.0021	CcSEcCtD
Methysergide—Oedema peripheral—Doxorubicin—uterine cancer	0.000508	0.00206	CcSEcCtD
Methysergide—Asthenia—Etoposide—uterine cancer	0.000506	0.00206	CcSEcCtD
Methysergide—Alopecia—Epirubicin—uterine cancer	0.000492	0.002	CcSEcCtD
Methysergide—Diarrhoea—Etoposide—uterine cancer	0.000483	0.00196	CcSEcCtD
Methysergide—Flushing—Doxorubicin—uterine cancer	0.000478	0.00194	CcSEcCtD
Methysergide—Back pain—Epirubicin—uterine cancer	0.000469	0.00191	CcSEcCtD
Methysergide—Dizziness—Etoposide—uterine cancer	0.000467	0.0019	CcSEcCtD
Methysergide—Alopecia—Doxorubicin—uterine cancer	0.000455	0.00185	CcSEcCtD
Methysergide—Ill-defined disorder—Epirubicin—uterine cancer	0.00045	0.00183	CcSEcCtD
Methysergide—Vomiting—Etoposide—uterine cancer	0.000449	0.00182	CcSEcCtD
Methysergide—Rash—Etoposide—uterine cancer	0.000445	0.00181	CcSEcCtD
Methysergide—Dermatitis—Etoposide—uterine cancer	0.000445	0.00181	CcSEcCtD
Methysergide—Malaise—Epirubicin—uterine cancer	0.000437	0.00178	CcSEcCtD
Methysergide—Back pain—Doxorubicin—uterine cancer	0.000434	0.00176	CcSEcCtD
Methysergide—Convulsion—Epirubicin—uterine cancer	0.00042	0.00171	CcSEcCtD
Methysergide—Nausea—Etoposide—uterine cancer	0.000419	0.0017	CcSEcCtD
Methysergide—Ill-defined disorder—Doxorubicin—uterine cancer	0.000416	0.00169	CcSEcCtD
Methysergide—Arthralgia—Epirubicin—uterine cancer	0.000413	0.00168	CcSEcCtD
Methysergide—Chest pain—Epirubicin—uterine cancer	0.000413	0.00168	CcSEcCtD
Methysergide—Myalgia—Epirubicin—uterine cancer	0.000413	0.00168	CcSEcCtD
Methysergide—Discomfort—Epirubicin—uterine cancer	0.000408	0.00166	CcSEcCtD
Methysergide—Malaise—Doxorubicin—uterine cancer	0.000404	0.00164	CcSEcCtD
Methysergide—Oedema—Epirubicin—uterine cancer	0.000396	0.00161	CcSEcCtD
Methysergide—Convulsion—Doxorubicin—uterine cancer	0.000389	0.00158	CcSEcCtD
Methysergide—Thrombocytopenia—Epirubicin—uterine cancer	0.000387	0.00157	CcSEcCtD
Methysergide—Tachycardia—Epirubicin—uterine cancer	0.000386	0.00157	CcSEcCtD
Methysergide—Chest pain—Doxorubicin—uterine cancer	0.000382	0.00155	CcSEcCtD
Methysergide—Arthralgia—Doxorubicin—uterine cancer	0.000382	0.00155	CcSEcCtD
Methysergide—Myalgia—Doxorubicin—uterine cancer	0.000382	0.00155	CcSEcCtD
Methysergide—Discomfort—Doxorubicin—uterine cancer	0.000377	0.00153	CcSEcCtD
Methysergide—Oedema—Doxorubicin—uterine cancer	0.000366	0.00149	CcSEcCtD
Methysergide—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.00036	0.00147	CcSEcCtD
Methysergide—Thrombocytopenia—Doxorubicin—uterine cancer	0.000358	0.00146	CcSEcCtD
Methysergide—Insomnia—Epirubicin—uterine cancer	0.000358	0.00145	CcSEcCtD
Methysergide—Tachycardia—Doxorubicin—uterine cancer	0.000357	0.00145	CcSEcCtD
Methysergide—Paraesthesia—Epirubicin—uterine cancer	0.000355	0.00144	CcSEcCtD
Methysergide—Dyspnoea—Epirubicin—uterine cancer	0.000353	0.00143	CcSEcCtD
Methysergide—Somnolence—Epirubicin—uterine cancer	0.000352	0.00143	CcSEcCtD
Methysergide—Dyspepsia—Epirubicin—uterine cancer	0.000348	0.00142	CcSEcCtD
Methysergide—Gastrointestinal disorder—Epirubicin—uterine cancer	0.000342	0.00139	CcSEcCtD
Methysergide—Fatigue—Epirubicin—uterine cancer	0.000341	0.00139	CcSEcCtD
Methysergide—Constipation—Epirubicin—uterine cancer	0.000338	0.00138	CcSEcCtD
Methysergide—Pain—Epirubicin—uterine cancer	0.000338	0.00138	CcSEcCtD
Methysergide—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.000333	0.00136	CcSEcCtD
Methysergide—Insomnia—Doxorubicin—uterine cancer	0.000331	0.00135	CcSEcCtD
Methysergide—Paraesthesia—Doxorubicin—uterine cancer	0.000329	0.00134	CcSEcCtD
Methysergide—Dyspnoea—Doxorubicin—uterine cancer	0.000326	0.00133	CcSEcCtD
Methysergide—Feeling abnormal—Epirubicin—uterine cancer	0.000326	0.00133	CcSEcCtD
Methysergide—Somnolence—Doxorubicin—uterine cancer	0.000325	0.00132	CcSEcCtD
Methysergide—Gastrointestinal pain—Epirubicin—uterine cancer	0.000323	0.00131	CcSEcCtD
Methysergide—Dyspepsia—Doxorubicin—uterine cancer	0.000322	0.00131	CcSEcCtD
Methysergide—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.000316	0.00128	CcSEcCtD
Methysergide—Fatigue—Doxorubicin—uterine cancer	0.000316	0.00128	CcSEcCtD
Methysergide—Constipation—Doxorubicin—uterine cancer	0.000313	0.00127	CcSEcCtD
Methysergide—Pain—Doxorubicin—uterine cancer	0.000313	0.00127	CcSEcCtD
Methysergide—Abdominal pain—Epirubicin—uterine cancer	0.000313	0.00127	CcSEcCtD
Methysergide—Body temperature increased—Epirubicin—uterine cancer	0.000313	0.00127	CcSEcCtD
Methysergide—Feeling abnormal—Doxorubicin—uterine cancer	0.000302	0.00123	CcSEcCtD
Methysergide—Gastrointestinal pain—Doxorubicin—uterine cancer	0.000299	0.00122	CcSEcCtD
Methysergide—Body temperature increased—Doxorubicin—uterine cancer	0.000289	0.00118	CcSEcCtD
Methysergide—Abdominal pain—Doxorubicin—uterine cancer	0.000289	0.00118	CcSEcCtD
Methysergide—Asthenia—Epirubicin—uterine cancer	0.000284	0.00115	CcSEcCtD
Methysergide—Diarrhoea—Epirubicin—uterine cancer	0.000271	0.0011	CcSEcCtD
Methysergide—Asthenia—Doxorubicin—uterine cancer	0.000263	0.00107	CcSEcCtD
Methysergide—Dizziness—Epirubicin—uterine cancer	0.000262	0.00106	CcSEcCtD
Methysergide—Vomiting—Epirubicin—uterine cancer	0.000252	0.00102	CcSEcCtD
Methysergide—Diarrhoea—Doxorubicin—uterine cancer	0.00025	0.00102	CcSEcCtD
Methysergide—Rash—Epirubicin—uterine cancer	0.000249	0.00101	CcSEcCtD
Methysergide—Dermatitis—Epirubicin—uterine cancer	0.000249	0.00101	CcSEcCtD
Methysergide—Dizziness—Doxorubicin—uterine cancer	0.000242	0.000984	CcSEcCtD
Methysergide—Nausea—Epirubicin—uterine cancer	0.000235	0.000955	CcSEcCtD
Methysergide—Vomiting—Doxorubicin—uterine cancer	0.000233	0.000946	CcSEcCtD
Methysergide—Rash—Doxorubicin—uterine cancer	0.000231	0.000938	CcSEcCtD
Methysergide—Dermatitis—Doxorubicin—uterine cancer	0.000231	0.000937	CcSEcCtD
Methysergide—Nausea—Doxorubicin—uterine cancer	0.000217	0.000884	CcSEcCtD
